(1)
Comparison of Adverse Events Between Selective Internal Radiation Therapy Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma in Mongolia: A Subgroup Analysis of SIRveNIB Study. Cent Asian J Med Sci 2017, 3 (3), 297-305. https://doi.org/10.24079/cajms.2017.11.011.